BSESupha Pharmachem LtdMediumNeutral
Announced Mon, 7 Apr · 14:48 IST

The Company has fixed Tuesday, 15th April, 2025 as Record Date for determining the equity shareholders entitled to receive rights entitlements in the Rights Issue.

Corporate Actions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Remedium Lifecare Limited (formerly Roxy Exports Limited) has fixed Tuesday, April 15, 2025 as the record date for identifying equity shareholders who will be entitled to receive rights entitlements in the company's upcoming Rights Issue. The communication was made under SEBI LODR Regulation 42 to BSE (Scrip Code: 539561, ISIN: INE549501036). The filing is a procedural notice and does not disclose the rights issue price, ratio, or total issue size. Investors must hold shares by the record date to be eligible to participate in the rights issue.

Likely market impact

This is a standard procedural step ahead of a rights issue. Shareholders who buy shares before April 15, 2025 will be eligible to receive rights entitlements. The actual dilution and cost to shareholders will depend on the rights issue terms (ratio and price) which are not mentioned in this filing.